Aleix Prat, Director of the Clinic Barcelona Comprehensive Cancer Center, shared a post on LinkedIn:
“Excited to be attending the JSMO Annual Meeting to discuss HER2DX and ADCs, two key advancements shaping the future of breast cancer treatment. This meeting will be a fantastic opportunity to engage with young medical oncologists, participate in high-impact discussions, and connect with the JSMO breast cancer team.
Looking forward to meaningful interactions, knowledge exchange, and collaborations that will drive innovation in oncology. See you in Japan!”
More posts featuring Aleix Prat.